Expansion of AI-driven MRI tech at Mount Sinai by end of 2024 | Binary | | | 7 months ago | |
Number of New AI Applications in Medical Imaging at Mount Sinai by 2024 | Categorical | | | 7 months ago | |
Will Thomas Fuchs remain Chief AI Officer of Eli Lilly through 2025? | Binary | | | 2 months ago | |
Will Mount Sinai announce a new closure date for Beth Israel Hospital by Dec 31, 2024? | Binary | | | 6 months ago | |
Level of MRI Image Resolution Improvement at Mount Sinai by 2024 | Categorical | | | 7 months ago | |
FDA approval for AI-enhanced 0.05T MRI by mid-2025 | Binary | | | 7 months ago | |
Adoption Rate of AI-Enhanced Low-Power MRI in Major Hospitals by 2024 | Categorical | | | 7 months ago | |
Will Eli Lilly implement AI-driven drug discovery process by end of 2025? | Binary | | | 2 months ago | |
How many AI-driven projects will Eli Lilly initiate in 2025? | Categorical | | | 2 months ago | |
Will Eli Lilly receive approval for AI-developed drug by end of 2026? | Binary | | | 2 months ago | |
Will Beth Israel Hospital remain open through the end of 2024? | Binary | | | 6 months ago | |
Will the FDA approve a new treatment for Long COVID based on the findings of the Iwasaki study by December 31, 2024? | Binary | | | 6 months ago | |
Cost reduction in MRI procedures at Mount Sinai by end of 2024 | Binary | | | 7 months ago | |
What will be the primary focus area for AI at Eli Lilly by end of 2025? | Categorical | | | 2 months ago | |
How will AI integration impact Eli Lilly's stock price by end of 2025? | Categorical | | | 2 months ago | |
What will be the status of Beth Israel Hospital by Dec 31, 2024? | Categorical | | | 6 months ago | |
Will the State government intervene to prevent the closure of Beth Israel Hospital by Dec 31, 2024? | Binary | | | 6 months ago | |
What will be the primary reason for the future decision about Beth Israel Hospital by Dec 31, 2024? | Categorical | | | 6 months ago | |
What will be the role of local leaders in the decision about Beth Israel Hospital by Dec 31, 2024? | Categorical | | | 6 months ago | |
What will be the major funding source for new Long COVID research initiatives based on the Iwasaki study by December 31, 2024? | Categorical | | | 6 months ago | |
Will Akiko Iwasaki or her colleagues publish a follow-up study on Long COVID by December 31, 2024? | Binary | | | 6 months ago | |
What will be the primary symptom targeted by new Long COVID treatments developed based on the Iwasaki study by December 31, 2024? | Categorical | | | 6 months ago | |
What will follow-up studies identify as the primary location of persistent SARS-CoV-2 in Long COVID patients by December 31, 2024? | Categorical | | | 6 months ago | |
Will the CDC introduce new Long COVID treatment guidelines based on the Iwasaki study by December 31, 2024? | Binary | | | 6 months ago | |